Translational Development Acquisition

Translational Development Acquisition Forward P/E

The Forward P/E Ratio of Translational Development Acquisition (TDAC) as of Nov 4, 2026 is 36.19. In the previous year, Forward P/E Ratio was -3,242.38 — a change of -101.12% (higher).

Forward P/E

36.19

YoY

-101.12%

Last updated:

Forward P/E Ratio of Translational Development Acquisition is 2025 36.19 . Forward P/E Ratio of Translational Development Acquisition was 2024 -3,242.38 . It decreases by -101.12% higher compared to the previous year.

The Translational Development Acquisition Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2022
-3,258.44 USD
Jan 1, 2023
-474.20 USD
Jan 1, 2024
-3,242.38 USD
Jan 1, 2025
36.19 USD
The Translational Development Acquisition Forward P/E history
YEARForward P/EYoY
36.19-101.12%
-3,242.38+583.76%
-474.20-85.45%
-3,258.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Translational Development Acquisition Stock analysis

What does Translational Development Acquisition do? Translational Development Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company has not selected any specific business combination target and has not engaged in any substantive discussions with potential targets. It has neither generated revenues nor conducted any operations since its formation. The firm's business model relies on identifying and executing a future business combination to create value for its shareholders. The company's primary revenue source will come from the successful completion of a business combination, which typically involves acquiring a target company or asset. As a blank check company, it does not operate any business or generate income until a merger or acquisition is finalized. The firm's investors, who purchase shares during its IPO, expect the company to identify and acquire a target business that will provide returns on their investment. Translational Development Acquisition Corp is structured as a special purpose acquisition company (SPAC) that has not yet identified a target business. Its success depends entirely on finding and merging with a suitable company within the timeframe specified in its prospectus. The firm's investors are the primary buyers of its shares, anticipating capital appreciation once a business combination is executed. Translational Development Acquisition is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Translational Development Acquisition stock

Forward P/E Ratio of Translational Development Acquisition is 36.19 in 2025.

Forward P/E Ratio of Translational Development Acquisition changed from -3,242.38 to 36.19, representing a -101.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Translational Development Acquisition since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Translational Development Acquisition with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Translational Development Acquisition

All Key Metrics — Translational Development Acquisition